Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Moving up strongly on the Swiss Exchange! Looks like a Green Day for shareholders! Could see the .70’s!
It appears to be so. Probably should be the “drug of choice” used for any lung related infections!
Although RLF was sinking on the Swiss Stock Exchange early this morning, it’s moving up again off its lows. Good news for those who are holding on to their shares!
Never underestimate the value of a life saving treatment for respiratory problems. Many people have died from respiratory infections related to other surgical procedures and pulmonary lung problems. RLF 100 will become a godsend for many respiratory issues.
This stock is just in the first inning of this ballgame!
Solid Science! Good News on Tommy! Great Results on Trials! More Good News Coming!
Expect it will be trading in the .60’s today!
My take on SBFM. They have manufactured in the labs four molecules that can be added to Big pharma’s drugs that add a means to destroy the molecules of viruses.
Seems to me that they have four molecules that can be added to the drugs of many large Pharma drug companies that will make their drugs more effective in treating viruses and cancers of all types. If true this will have a very significant impact on the entire pharmaceutical industry on a broad range of diseases.
Just my opinion. I am not a medical expert
Setting up nicely. May break into the sixes today!
Excellent Point!
Remember when Tommy was on 100% ventilation and the ECMO. At that point he was totally reliant on devices outside his body for survival. His ventilator is now at 40%. That is miraculous! Thanks for the support and the many prayers offered by his family, friends and those on the hub!
Data security will be much needed as digital cryptocurrency becomes ever more popular. ATDS will be a big player in this market, for sure!
Why would any financial institution (GEM) invest that kind of money ($750M) in a company unless they had a promising future. The promising future is the COVID 19 cure!
There is increasing awareness that COVID-19 Life or Death has to do with the lungs. The best drug available on the market that fights off the disease and protects the lungs is RFL-100. Once that becomes clear to the medical community, it will draw everyone’s attention to Relief Therapeutics. RFL-100 is the “Silver Bullet!”
So if you can’t get the plasma treatment within 3 days, it is useless. Typical scenario would be as follows:
Clinician question: “How long have you had the coronavirus?”
Patient Answer: “I don’t know.
Clinician response: “We cannot do the plasma treatment on you because it cannot be successful unless you can provide the date and time of the infection. Suggest we try RLF-100!”
Patient response: Give me the RLF-100.
Clinician: “Also, here is the RLF nebulizer which you need to take whenever you go out in public.”
Patient response: “Thanks!”
Confidence level in a plasma treatment protecting me from the coronavirus: 10%
Bottom Line: So if one wants to protect him or herself from the coronavirus, he or she gets the plasma transfusion and he still has a 65% chance of getting the coronavirus. Sounds like a “definite maybe” to me!
RLF-100 would likely have a 100% success rate for moderately ill patients with COVID-19 and a 95% success rate with critically ill patients. There is not another drug on the market that can achieve that kind of efficacy. Not to mention no major side effects and virtually 100% patient safety. THIS SHOULD BE THE REAL STORY!
Plasma has risks. It can transmit HIV.
He needs to fire Doctor Hahn at the FDA. He must be a deep state operative. RLF 100 is 95% effective. We still have a strong horse in this race for treatment!
35% survival of COVID 19 patients with treatment by convalescent plasma treatment. Not very efficient!
Lasix also known as furosemide is a drug commonly used for people who have congestive heart failure! This drug is used to naturally extract water out out of the body. Congestive heart failure is a heart condition that has a low ejection factor and can’t keep all the organs functioning properly and water floods the body. Lasix puts the kidneys on overtime to drain the bodily fluids. RLF100 helps with assisting the lung function as we all know. They both are complimentary drugs to assist the patient‘s heart and lungs.
Looking strong here. Power hour coming up. May test the sevens. Hold on to your hats!
If this stock moves well on no news, imagine how it will move on real news. I can only imagine!
We’ll be in the sixes soon!
This horse is a snorting “black stallion” and its ready to run!
Like what’s happening here! This may run hard by the end of the day!
Looks like the bid/ask cumulative volume may be forming up for a run into the sixes
RLF100 will be the “shot heard around the world!”
Looks like the Swiss “shorts” yesterday “took it in the shorts today!”
Funny watching the Swiss “shorts” get pounded this morning!
“The slow march upwards begins!”
Swiss Exchange :
Stock may finish in the green!
Swiss Exchange:
Stock recovering nicely. Breaking into the 5’s!
Swiss Exchange:
Very thin cumulative totals on the ask.
Price expected to move up significantly
to close the gap before closing!
As the saying goes for the Swiss exchange:
You can’t fix stupid!
Know when to hold em!
Houston Methodist RLF100 Results: $$$
Partnership Announcement: $$$$$$
FDA Approval Announcement: $$$$$$$$$$$$
If this opens lower, I will simply buy more!
He has the connections to get the attention needed to succeed in getting the exposure this drug deserves when navigating the pharmaceutical bureaucratic morass!
The cost of the RFL100 drug to cure a patient has to be weighed against the
The cost of ventilators which range from $25,000.00 to $50,000.00. This drug will offset the cost of ventilators in hospitals around the world.
Question: How much savings would severe cases treated with Injected Aviptadil. Also, ventilators don’t save lives but simply extend it. How much revenue would result from hospitals substituting the Aviptadil drug for ventilators?
Also, when checking the cost of asthma or allergy inhalers can cost up to $50.00. What would be the price of a Aviptadil inhaler?
If an allergy or asthma inhaler sells for $50.00, what will be the cost of an Aviptadil inhaler. How many people would need to buy one. If an Aviptadil inhaler were $50.00 and billions of people needed to buy one, how much revenue would that bring in?
One can only imagine!
Also, I believe something big may be going on behind the scenes with Zoom Telephonics! Just my guess!
Let’s change the subject and get off Russia.
Question: What do we think is going to happen to RLFTF on the European Swiss Stock Exchange?
My Take: There was a ton of selling with people jumping ship left and right. After the Europeans now see that the rumors have subsided and the panic selling has ceased the buying will continue. I expect the buyers, having realized they overreacted to the reports on the 2% sale of holdings by an executive and the threat of a largely unverified Russian vaccine with very limited trials, will very likely return in droves tomorrow to buy shares in RLFTF. I believe the stock will run strong in the morning hours overseas and suspect the stock will close in the 70’s.
I expect the buying will continue in the US when the market opens here.
It should be a great day for those on both sides of the pond that choose to buy the stock tomorrow. IMHO!